News

Lodotra, used in the treatment of rheumatoid arthritis (RA), is a programmed-release formulation of low dose prednisone, that is developed using SkyePharma’s Geoclock technology in collaboration with Horizon.

Huron Life Sciences’ Click Portal software is believed to help re-engineer specific processes, streamline information flows, provide accurate detailed budgets, and eliminate billing inconsistencies. The new software will

Cabozantinib is a potent, dual inhibitor of MET and VEGFR2. Exelixis and the NCI will carry out a series of clinical trials to assess the safety and efficacy

Eylea, also known VEGF Trap-Eye, is a recombinant fusion protein, consisting of portions of human VEGF receptors 1 and 2 extracellular domains fused to the Fc portion of

Following the authorization, Eviplera will be made commercially available in all 27 countries of the European Union (EU). Eviplera combines Gilead’s Truvada, a fixed-dose combination of the two

The institute will transform basic discoveries into new drugs and complementary diagnostics for cancer patients besides improving translational and clinical research, newswise.com reported. MD Anderson president Ronald DePinho

The initiative is believed to help small and large companies to lease the facilities needed to produce FDA regulated material. According to the company, this program will allow

Under the terms of the agreement, the Japanese agency will support State Pharmaceutical Corporation of Sri Lanka in the production of drugs locally, news.lk reported. Currently, 50 varieties

Blinatumomab is a next-generation monoclonal antibody designed to direct the body’s cell destroying T-cells against CD19, a protein expressed on the surface of B-cell derived acute lymphoblastic leukemias